Southern Illinois University Edwardsville

SPARK
Doctor of Nursing Practice Projects

School of Nursing

Spring 5-10-2019

Depression Screening in the Primary Care Setting
Colleen Dostal
Stephanie Boerding

Follow this and additional works at: https://spark.siue.edu/dnpprojects
Part of the Nursing Commons
Recommended Citation
Dostal, Colleen and Boerding, Stephanie, "Depression Screening in the Primary Care Setting" (2019). Doctor of Nursing Practice
Projects. 37.
https://spark.siue.edu/dnpprojects/37

This DNP Project is brought to you for free and open access by the School of Nursing at SPARK. It has been accepted for inclusion in Doctor of
Nursing Practice Projects by an authorized administrator of SPARK. For more information, please contact magrase@siue.edu.

Executive Summary
Depression Screening in the Primary Care Setting
Colleen Dostal and Stephanie Boerding
Introduction of Problem
Recent data reveals an estimated 17.3 million adults in the US population experience an
episode of depression each year (NIH, 2019); making this the second leading cause of disability
in the country (McGough, Bauer, Collins, Dugdale, 2016). Eighty percent of depression is
diagnosed in primary care; therefore, it is important that primary care providers are evaluating
and treating this condition (McGough, Bauer, Collins, and Dugdale, 2016). Unidentified and
untreated depression has many consequences leading to a poor quality of life, direct and indirect
healthcare cost-related increases, and an increase in medical comorbidities (Halverson, 2017).
Approximately 45% of those who die by suicide were seen by their primary care provider in the
month prior to the event (Raue, Ghesquiere, & Bruce, 2014). If there is a lack of standardized
screening, primary care providers may overlook at least 50% of patients that have depression
(Arroll, et. al., 2010). It is vital that depression is identified early and treated effectively to
prevent these complications.
Literature Review
Depression cannot be diagnosed by laboratory or diagnostic testing; therefore, it is
essential that a screening tool is implemented in all primary care offices (Halverson, 2017). The
U.S. Preventative Services Task Force recommends that all adults be screened for depression.
The PHQ-2 and PHQ-9 are the most widely accepted screening tools that have been proven to be
efficient and accurate in the preliminary detection of depression (Haefner, Daly, & Russell,
2017). The PHQ-2 is used to initially screen every patient at every visit with two questions

regarding feelings of depression or loss of interest in activities they once enjoyed in the last two
weeks. If the patient answers yes to either of these questions, they are then screened with a more
in depth questionnaire, the PHQ-9. The PHQ-2 is highly reliable at ruling out depression with a
sensitivity of 97% while the PHQ-9 is highly reliable at ruling in depression with a specificity of
94% (Maurer, 2012). The conjunctive use of both of these questionnaires can therefore provide
the primary care provider with a more accurate screening of patients with depression. By
administering the PHQ-2 and PHQ-9 at the same visit if the patient screens positively, earlier
identification and treatment may be initiated.
Project Methods
As a quality improvement project, a new protocol for depression screening was
implemented at the SIUE We Care Clinic in East St. Louis, IL. This clinic’s previous policy for
screening depression involved two stages. First, the PHQ-2 was administered. In the event the
patient scored a two or higher on this PHQ-2, they were requested to make a follow-up
appointment with the clinic for administration of the PHQ-9, risking failure to follow through.
The purpose of the project was to educate health care professionals regarding depression
and to implement a more timely depression screening protocol in this primary care setting. The
intent of this project was to improve identification rates of people suffering from depression,
leading to earlier intervention and treatment. An additional purpose of this project was to
educate health care providers regarding proper coding of depression screening administration so
that the clinic would receive maximum reimbursement. The population used in this study
included adults aged 18-99, predominantly African American, and medically underserved. The
three project goals were: complete a full depression screen at a single visit; increase the rates of
administration of the PHQ-2 and PHQ-9 to better identify patients suffering from depression,

resulting in earlier intervention; appropriate coding for administration of the PHQ-2 and PHQ-9
with subsequent reimbursement.
An educational in-service was provided to the SIUE We Care Clinic staff which included
background information on depression, the clinical relevance of a depression screening tool in
the primary care setting, and implementation of the depression screening protocol. The proper
use, reliability, and validity of the PHQ-2 and PHQ-9 were discussed in detail. The new protocol
that the clinic adopted was to administer the PHQ-2 to all patients. If the patient screened
positively on the PHQ-2, the patient would then be screened with the PHQ-9 in the same visit so
early intervention could be made.
This project was deemed exempt from the Institutional Review Board at Southern Illinois
University Edwardsville. Data collection was done retrospectively. There were no threats to
subject welfare due to the method of data collection.
Evaluation
To analyze project goals, data was collected that included the following: the compliance
rates of administering the PHQ-2 and PHQ-9 prior to and after the educational in-service, the
number of patients identified with depression before and after implementation of the new
depression screening protocol, and the clinic’s reimbursement after proper coding for these
screenings.
Prior to the project implementation, data was collected from patient visits through the
dates of 9/28/17 – 12/28/17 (n=209). In this analysis 72 (34%) patients screened positively for
depression with the PHQ-2; 137 (66%) patients were not screened. Of the patients that received
the depression screening tool, 16 (22%) patients screened positively for depression.

After project implementation, the number of patients seen from 8/27/18 – 11/27/18
numbered 145. Ninety-seven (67%) patients were screened for depression with the PHQ-2 and
48 (33%) patients were not screened. Of those screened, 22 (23%) patients screened positively
on the PHQ-2. These 22 (100%) patients that screened positively on the PHQ-9 were
immediately referred for further evaluation, diagnosis, and potential treatment.
When comparing the data, a 33% increase in the number of patients that were screened
for depression was found. This indicates that the educational in-service led to more patients
being screened for depression. In addition, 100% of patients that screened positively on the
PHQ-2 were then screened in the same visit with the PHQ-9 and identified with symptoms of
depression. These patients were then promptly referred for treatment to social work, counseling,
and/or received medication intervention in that same visit. These findings indicate that the new
protocol was effective and more patients could be promptly identified with depression when in
use. Prompt identification, in turn, resulted in rapid intervention thus reducing the potential
consequences of untreated depression from occurring and improving the quality of one’s life.
Additionally, at the time of data collection, the clinic had not received all claims but had seen
reimbursements totaling $176.00. This was an improvement as, prior to project implementation,
the clinic had not been coding or receiving reimbursement for the administration of depression
screening tools.
Limitations of this project include limited time and a small sample size. This was due to
the clinic’s lack of operation over the summer of 2018. Patient cancellations and no-shows also
contributed to a small sample size. Strengths of this project include positive data results with
subsequent adoption of the proposed depression screening protocol. This project can also be
easily replicated.

Impact on Practice
This project was clinically relevant as it led to an increase in the identification of patients
with depression and prompt intervention. Prior to this project, the SIUE We Care Clinic was
administering the PHQ-2 and the PHQ-9 in separate visits and was not coding for either
assessment. Results of this project indicate that the educational in-service heightened awareness
for the need to administer the PHQ-2 and the PHQ-9 in the same visit to identify depression and
prompt intervention/treatment. Results also indicate that education regarding the proper coding
of these services led to reimbursement and revenue for the clinic. The clinic currently plans to
continue the new depression screening protocol in addition to billing for these services. It is
expected that more patients will be identified with depression and receive prompt treatment. The
clinic will continue to receive reimbursements for these screenings with the appropriate coding
and billing.
Conclusion
Depression screening outcomes may be improved by educating clinic staff about the
administration of the PHQ-2 and the PHQ-9. The literature supports that the current protocol of
administering these tools within the same visit and to all patients leads to improved identification
of those suffering from depression. With the adoption of this protocol, more patients will be
screened and identified with depression leading to prompt intervention and treatment.
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